Michael S. Sherman

1.5k total citations
45 papers, 1.1k citations indexed

About

Michael S. Sherman is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Michael S. Sherman has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Public Health, Environmental and Occupational Health and 7 papers in Neurology. Recurrent topics in Michael S. Sherman's work include Respiratory Support and Mechanisms (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Michael S. Sherman is often cited by papers focused on Respiratory Support and Mechanisms (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Michael S. Sherman collaborates with scholars based in United States, Peru and Australia. Michael S. Sherman's co-authors include Terry Heiman‐Patterson, Gary Romano, Kleopas A. Kleopa, Juliana Cepelowicz Rajter, Fabio Vogel, Naaz Fatteh, Harold L. Paz, David B. Campbell, Harry Peled and Eliot J. Lazar and has published in prestigious journals such as CHEST Journal, The Journal of Pediatrics and American Heart Journal.

In The Last Decade

Michael S. Sherman

45 papers receiving 997 citations

Peers

Michael S. Sherman
R. Gentry Wilkerson United States
Rana Hejal United States
Arunabh Talwar United States
Robert Angus United Kingdom
Michael S. Sherman
Citations per year, relative to Michael S. Sherman Michael S. Sherman (= 1×) peers Riccardo Lubrano

Countries citing papers authored by Michael S. Sherman

Since Specialization
Citations

This map shows the geographic impact of Michael S. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Sherman more than expected).

Fields of papers citing papers by Michael S. Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Sherman. The network helps show where Michael S. Sherman may publish in the future.

Co-authorship network of co-authors of Michael S. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Sherman. A scholar is included among the top collaborators of Michael S. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Sherman. Michael S. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Younossi, Zobair M., Homie Razavi, Michael S. Sherman, et al.. (2025). Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction‐Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective. Alimentary Pharmacology & Therapeutics. 61(9). 1467–1478. 8 indexed citations
2.
Schroeder, Brock E., et al.. (2021). Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement. PharmacoEconomics - Open. 5(3). 449–458. 4 indexed citations
3.
Rajter, Juliana Cepelowicz, et al.. (2020). Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019. CHEST Journal. 159(1). 85–92. 172 indexed citations
4.
Mattie, Heather, Patrick Reidy, Patrik Bächtiger, et al.. (2019). A Framework for Predicting Impactability of Digital Care Management Using Machine Learning Methods. Population Health Management. 23(4). 319–325. 6 indexed citations
5.
Scoy, Lauren J. Van, Jean M. Reading, Judie A. Howrylak, Ashutosh Tamhane, & Michael S. Sherman. (2016). Low quality of dying and death in patients with septic shock as perceived by nurses and resident physicians. Death Studies. 40(8). 486–493. 2 indexed citations
6.
Sherman, Michael S., et al.. (2014). Cardiopulmonary Response to Videogaming: Slaying Monsters Using Motion Sensor Versus Joystick Devices. Games for Health Journal. 3(5). 284–290. 2 indexed citations
7.
Scoy, Lauren J. Van & Michael S. Sherman. (2013). Factors Affecting Code Status in a University Hospital Intensive Care Unit. Death Studies. 37(8). 768–781. 3 indexed citations
8.
Lang, David M., Marcia Polansky, & Michael S. Sherman. (2009). Hospitalizations for asthma in an urban population: 1995–1999. Annals of Allergy Asthma & Immunology. 103(2). 128–133. 16 indexed citations
9.
Sherman, Michael S., et al.. (2004). Inhalation of Crack Cocaine Can Mimic Pulmonary Embolism. Clinical Nuclear Medicine. 29(11). 756–757. 12 indexed citations
10.
Sherman, Michael S., et al.. (2004). Standard Equations Are Not Accurate in Assessing Resting Energy Expenditure in Patients With Amyotrophic Lateral Sclerosis. Journal of Parenteral and Enteral Nutrition. 28(6). 442–446. 43 indexed citations
11.
Grewal, Ravinder K., Simin Dadparvar, Jian Yu, et al.. (2002). Efficacy of Tc-99m Depreotide Scintigraphy in the Evaluation of Solitary Pulmonary Nodules. The Cancer Journal. 8(5). 400–404. 25 indexed citations
12.
Kleopa, Kleopas A., et al.. (1999). Bipap improves survival and rate of pulmonary function decline in patients with ALS. Journal of the Neurological Sciences. 164(1). 82–88. 294 indexed citations
14.
Sherman, Michael S., et al.. (1997). Pulmonary dysfunction and reduced exercise capacity in patients with myelomeningocele. The Journal of Pediatrics. 131(3). 413–418. 32 indexed citations
15.
Sherman, Michael S., Amir Matityahu, & David A. Campbell. (1996). A method for estimating respiratory muscle efficiency using an automated metabolic cart. Respiration Physiology. 106(2). 171–177. 1 indexed citations
16.
Sherman, Michael S.. (1994). A Predictive Equation for Determination of Resting Energy Expenditure in Mechanically Ventilated Patients. CHEST Journal. 105(2). 544–549. 6 indexed citations
17.
Sherman, Michael S. & Harold L. Paz. (1994). Review of Respiratory Care of the Patient with Amyotrophic Lateral Sclerosis. Respiration. 61(2). 61–67. 36 indexed citations
18.
Sherman, Michael S., et al.. (1990). Aspiration Pneumonia due to Diffuse Cervical Hyperostosis. CHEST Journal. 98(3). 763–764. 21 indexed citations
19.
Sherman, Michael S., et al.. (1988). The Effect of Digoxin on Contractility and Fatigue of Isolated Guinea Pig and Rat Hemidiaphragms. American Review of Respiratory Disease. 138(5). 1180–1184. 4 indexed citations
20.
Lazar, Eliot J., Jeffrey J. Goldberger, Harry Peled, Michael S. Sherman, & William H. Frishman. (1988). Atrial infarction: Diagnosis and management. American Heart Journal. 116(4). 1058–1063. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026